| Pulse Biosciences, Inc Common Stock (DE) | $1.7b | $26.70 | +7.4% | 247.4K | |
| Arbutus Biopharma Corporation Common Stock | $0.9b | $4.41 | -1.0% | 2.4M | |
| Rani Therapeutics Holdings, Inc. Class A Common Stock | $106.9m | $0.75 | -2.5% | 452.4K | |
| Clene Inc. Common Stock | $83.8m | $5.76 | +3.7% | 104.6K | |
| Zentek Ltd. Common Stock | $63.8m | $0.43 | 0.0% | 94.6K | |
| NanoViricides Inc. | $40.5m | $1.32 | -4.4% | 286.2K | |
| Polyrizon Ltd. Ordinary Shares | $32.1m | $11.54 | 0.0% | 13.7K | |
| Lexaria Bioscience Corp. Common Stock | $14.9m | $0.55 | +2.4% | 67.8K | |
| Aspire Biopharma Holdings, Inc. Common Stock | $7.1m | $6.20 | -1.6% | 67.4K | |
| TransCode Therapeutics, Inc. Common Stock | $4.9m | $4.57 | -7.5% | 29.5K |